In a recent study published in PLoS ONE, researchers explored the activity of angiotensin-converting enzyme-2 (ACE2) decoy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback